Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies
2018 · The Lancet Diabetes & Endocrinology · 315 citations
https://doi.org/10.1016/s2213-8587(18)30071-8